Heamofer Use In Pregnancy & Lactation

There are no adequate and well-controlled trials of HEAMOFER 20 in pregnant women. A careful risk/benefit evaluation is therefore required before use during pregnancy and Iron Sucrose should not be used during pregnancy unless clearly necessary.
Iron deficiency anaemia occurring in the first trimester of pregnancy can in many cases be treated with oral iron. Treatment with Iron Sucrose Injection should be confined to second and third trimester if the benefit is judged to outweigh the potential risk for both the mother and the foetus. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development. Data on a limited number of exposed human pregnancies indicated no adverse effects of Iron Sucrose on pregnancy or on the health of the foetus/newborn child.
Non metabolized Iron Sucrose is unlikely to pass into the mother's milk. No well-controlled clinical studies are available to date. Animal studies do not indicate direct or indirect harmful effects to the nursing child.